UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Assessment of bacterial quality of honey produced in Tamale metropolis (Ghana)

Journal of food and drug analysis, 2017-04, Vol.25 (2), p.369-373

2017

Volltextzugriff (PDF)

Improved glucose recovery from durian peel by alkaline-catalyzed steam pretreatment

PeerJ (San Francisco, CA), 2021-08, Vol.9, p.e12026-e12026, Article e12026

2021

Volltextzugriff (PDF)

Combining Autoclaving with Mild Alkaline Solution as a Pretreatment Technique to Enhance Glucose Recovery from the Invasive Weed Chloris barbata

Biomolecules (Basel, Switzerland), 2019-03, Vol.9 (4), p.120

2019

Volltextzugriff (PDF)

Fermentable Sugar Production from the Peels of Two Durian (Durio zibethinus Murr.) Cultivars by Phosphoric Acid Pretreatment

Resources (Basel), 2018-09, Vol.7 (4), p.60

2018

Volltextzugriff (PDF)

Intergeneric Hybrid from Jatropha curcas L. and Ricinus communis L.: Characterization and Polyploid Induction

Biology (Basel, Switzerland), 2019-06, Vol.8 (2), p.50

2019

Volltextzugriff (PDF)

Physicochemical Characterization of Jatropha podagrica Seed Oil for Potential Biodiesel Production and other Industrial Applications in Thailand

Sains Malaysiana, 2021-01, Vol.50 (1), p.85-92

2021

Volltextzugriff (PDF)

Enzymatic response to structural and chemical transformations in Hibiscus sabdariffa var. altissima bark and core during phosphoric acid pretreatment

Bioresources, 2019, Vol.13 (3), p.6778-6789

2019

Volltextzugriff (PDF)

Melanoma Epidemiology-Pivoting to Low- and Middle-Income Countries

JAMA dermatology (Chicago, Ill.), 2022-05, Vol.158 (5), p.489

2022

Volltextzugriff (PDF)

Cost-effectiveness analysis of later-line therapies for metastatic colorectal cancer (mCRC) based on a novel methodology of network meta-analysis (NMA) of survival curves

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3605-3605

2023

Volltextzugriff (PDF)

Comparative efficacy of later-line therapies for metastatic colorectal cancer (mCRC) using novel methods for patient survival data reconstruction and network meta-analysis (NMA) of survival curves

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15611-e15611

2023

Volltextzugriff (PDF)

Cost-utility analyses of later-line treatments for metastatic colorectal cancer (mCRC) by network meta-analysis (NMA) approach: Conventional constant hazard ratio vs novel survival curves methodologies

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18928-e18928

2023

Volltextzugriff (PDF)

The economic burden of Ebola virus disease: a review and recommendations for analysis

Journal of medical economics, 2024, Vol.27 (1), p.309-323

2024

Volltextzugriff (PDF)

Network meta-analysis (NMA) of second-line (2L) treatment options in metastatic renal cell carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.337-337

2022

Volltextzugriff (PDF)

EE58 Value-Based Pricing of an Ebola Vaccine in Resource-Constrained Countries Based on Cost-Effectiveness Analysis

Value in health, 2022-07, Vol.25 (7), p.S346-S347

2022

Volltextzugriff (PDF)

Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis

Journal of medical economics, 2022-12, Vol.25 (1), p.894-902

2022

Volltextzugriff (PDF)

Overall survival, efficacy, and safety outcomes beyond front-line modern therapies in metastatic clear-cell renal cell carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.667-667

2023

Volltextzugriff (PDF)

Economic evaluation of six and 12 month (m) treatment with isatuximab and carfilzomib and dexamethasone (IKd) versus daratumumab and carfilzomib and dexamethasone (DKd) in patients with relapsed or refractory multiple myeloma (RRMM)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20010-e20010

2021

Volltextzugriff (PDF)

Ixazomib (IXA), carfilzomib (CAR), elotuzumab (ELO) or daratumumab (DAR) with lenalidomide and dexamethasone (LEN+DEX) versus LEN+DEX only in relapsed/refractory multiple myeloma (R/R MM): A comparative cost-effectiveness analysis

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8043-8043

2021

Volltextzugriff (PDF)

Novel application of Kaplan-Meier methods to model tolerance for nonadherence to imatinib in patients with chronic myeloid leukemia (CML) in the ADAGIO study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7038-7038

2021

Volltextzugriff (PDF)

Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 2 disease

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20506-e20506

2022

Volltextzugriff (PDF)

Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 3A disease

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20505-e20505

2022

Volltextzugriff (PDF)

Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves

Expert review of pharmacoeconomics & outcomes research, 2024-06, p.1-10

2024

Volltextzugriff (PDF)

Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 1B disease

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20502-e20502

2022

Volltextzugriff (PDF)

Network meta-analysis of second line and beyond treatment options in metastatic clear cell renal cell carcinoma

Urologic oncology, 2024-02, Vol.42 (2), p.32.e1-32.e8

2024

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)
Berichte
(2)

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessment of bacterial quality of honey produced in Tamale metropolis (Ghana)

Improved glucose recovery from durian peel by alkaline-catalyzed steam pretreatment

Combining Autoclaving with Mild Alkaline Solution as a Pretreatment Technique to Enhance Glucose Recovery from the Invasive Weed Chloris barbata

Fermentable Sugar Production from the Peels of Two Durian (Durio zibethinus Murr.) Cultivars by Phosphoric Acid Pretreatment

Intergeneric Hybrid from Jatropha curcas L. and Ricinus communis L.: Characterization and Polyploid Induction

Physicochemical Characterization of Jatropha podagrica Seed Oil for Potential Biodiesel Production and other Industrial Applications in Thailand

Enzymatic response to structural and chemical transformations in Hibiscus sabdariffa var. altissima bark and core during phosphoric acid pretreatment

Immunomodulation and Humoral Immune Response in Teleost Immunized with Aeromonas-Derived Antigenic Extracellular Bioactive Molecules

Melanoma Epidemiology-Pivoting to Low- and Middle-Income Countries

Cost-effectiveness analysis of later-line therapies for metastatic colorectal cancer (mCRC) based on a novel methodology of network meta-analysis (NMA) of survival curves

Comparative efficacy of later-line therapies for metastatic colorectal cancer (mCRC) using novel methods for patient survival data reconstruction and network meta-analysis (NMA) of survival curves

Cost-utility analyses of later-line treatments for metastatic colorectal cancer (mCRC) by network meta-analysis (NMA) approach: Conventional constant hazard ratio vs novel survival curves methodologies

The economic burden of Ebola virus disease: a review and recommendations for analysis

Network meta-analysis (NMA) of second-line (2L) treatment options in metastatic renal cell carcinoma

EE58 Value-Based Pricing of an Ebola Vaccine in Resource-Constrained Countries Based on Cost-Effectiveness Analysis

Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis

Overall survival, efficacy, and safety outcomes beyond front-line modern therapies in metastatic clear-cell renal cell carcinoma

Economic evaluation of six and 12 month (m) treatment with isatuximab and carfilzomib and dexamethasone (IKd) versus daratumumab and carfilzomib and dexamethasone (DKd) in patients with relapsed or refractory multiple myeloma (RRMM)

Ixazomib (IXA), carfilzomib (CAR), elotuzumab (ELO) or daratumumab (DAR) with lenalidomide and dexamethasone (LEN+DEX) versus LEN+DEX only in relapsed/refractory multiple myeloma (R/R MM): A comparative cost-effectiveness analysis

Novel application of Kaplan-Meier methods to model tolerance for nonadherence to imatinib in patients with chronic myeloid leukemia (CML) in the ADAGIO study

Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 2 disease

Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 3A disease

Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves

Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 1B disease

Network meta-analysis of second line and beyond treatment options in metastatic clear cell renal cell carcinoma

Suchergebnisse filtern